Steven Valiquette
Stock Analyst at Mizuho
(2.75)
# 1,901
Out of 4,712 analysts
103
Total ratings
54.72%
Success rate
2.77%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Outperform | $275 → $280 | $216.55 | +29.30% | 2 | Dec 9, 2024 | |
| LFMD LifeMD | Initiates: Neutral | $7 | $4.91 | +42.57% | 1 | Dec 4, 2024 | |
| DOCS Doximity | Initiates: Neutral | $55 | $58.27 | -5.61% | 1 | Dec 4, 2024 | |
| HQY HealthEquity | Initiates: Outperform | $126 | $95.68 | +31.69% | 1 | Dec 4, 2024 | |
| XRAY DENTSPLY SIRONA | Initiates: Neutral | $21 | $18.90 | +11.11% | 6 | Dec 4, 2024 | |
| HSIC Henry Schein | Initiates: Neutral | $75 | $70.01 | +7.13% | 5 | Dec 4, 2024 | |
| SOLV Solventum | Initiates: Neutral | $70 | $66.56 | +5.17% | 1 | Dec 4, 2024 | |
| TALK Talkspace | Initiates: Outperform | $5 | $3.02 | +65.56% | 1 | Dec 4, 2024 | |
| NVST Envista Holdings | Initiates: Underperform | $20 | $18.95 | +5.54% | 1 | Dec 4, 2024 | |
| OMI Owens & Minor | Maintains: Equal-Weight | $18 → $14 | $12.72 | +10.06% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $180.38 | -21.28% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $59.23 | -7.13% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $126.59 | -27.32% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $118.83 | -28.47% | 5 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $506.10 | +11.64% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $44.25 | +125.99% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $3.77 | +271.35% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $295.19 | +35.51% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $60.83 | +75.90% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $27.39 | -37.93% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $5.07 | +136.92% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $475 → $555 | $213.50 | +159.95% | 9 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $94.17 | +1.94% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $166 | $579.13 | -71.34% | 2 | Nov 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $153.42 | -21.78% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $304.62 | -58.31% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $255.52 | +40.11% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $20 → $16 | $30.90 | -48.22% | 3 | Aug 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $9.19 | +552.88% | 3 | Apr 3, 2019 |
Veeva Systems
Dec 9, 2024
Maintains: Outperform
Price Target: $275 → $280
Current: $216.55
Upside: +29.30%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $4.91
Upside: +42.57%
Doximity
Dec 4, 2024
Initiates: Neutral
Price Target: $55
Current: $58.27
Upside: -5.61%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $95.68
Upside: +31.69%
DENTSPLY SIRONA
Dec 4, 2024
Initiates: Neutral
Price Target: $21
Current: $18.90
Upside: +11.11%
Henry Schein
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $70.01
Upside: +7.13%
Solventum
Dec 4, 2024
Initiates: Neutral
Price Target: $70
Current: $66.56
Upside: +5.17%
Talkspace
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $3.02
Upside: +65.56%
Envista Holdings
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $18.95
Upside: +5.54%
Owens & Minor
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $12.72
Upside: +10.06%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $180.38
Upside: -21.28%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $59.23
Upside: -7.13%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $126.59
Upside: -27.32%
Jun 12, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $118.83
Upside: -28.47%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $506.10
Upside: +11.64%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $44.25
Upside: +125.99%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $3.77
Upside: +271.35%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $295.19
Upside: +35.51%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $60.83
Upside: +75.90%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $27.39
Upside: -37.93%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $5.07
Upside: +136.92%
Feb 4, 2021
Maintains: Equal-Weight
Price Target: $475 → $555
Current: $213.50
Upside: +159.95%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $94.17
Upside: +1.94%
Nov 2, 2020
Upgrades: Overweight
Price Target: $166
Current: $579.13
Upside: -71.34%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $153.42
Upside: -21.78%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $304.62
Upside: -58.31%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $255.52
Upside: +40.11%
Aug 30, 2019
Maintains: Underweight
Price Target: $20 → $16
Current: $30.90
Upside: -48.22%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $9.19
Upside: +552.88%